Serum matrix metalloproteinase-9 (MMP-9) as a biomarker in paediatric and adult tick-borne encephalitis patients

. 2023 Jan 15 ; 324 () : 199020. [epub] 20221215

Jazyk angličtina Země Nizozemsko Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid36528170

Matrix metalloproteinases (MMPs) play an important role in central nervous system infections. We analysed the levels of 8 different MMPs in the cerebrospinal fluid (CSF) of 89 adult patients infected with tick-borne encephalitis (TBE) virus and compared them with the levels in a control group. MMP-9 was the only MMP that showed significantly increased CSF levels in TBE patients. Serum MMP-9 levels were subsequently measured in 101 adult TBE patients at various time points during the neurological phase of TBE and at follow-up. In addition, serum MMP-9 was analysed in 37 paediatric TBE patients. Compared with control levels, both paediatric and adult TBE patients had significantly elevated serum MMP-9 levels. In most adult patients, serum MMP-9 levels peaked at hospital admission, with higher serum MMP-9 levels observed in patients with encephalitis than in patients with meningitis. Elevated serum MMP-9 levels were observed throughout hospitalisation but decreased to normal levels at follow-up. Serum MMP-9 levels correlated with clinical course, especially in patients heterozygous for the single-nucleotide polymorphism rs17576 (A/G; Gln279Arg) in the MMP9 gene. The results highlight the importance of MMP-9 in the pathogenesis of TBE and suggest that serum MMP-9 may serve as a promising bioindicator of TBE in both paediatric and adult TBE patients.

Zobrazit více v PubMed

Barkhash A.V., Yurchenko A.A., Yudin N.S., Ignatieva E.V., Kozlova I.V., Borishchuk I.A., Pozdnyakova L.L., Voevoda M.I., Romaschenko A.G. A matrix metalloproteinase 9 (MMP9) gene single nucleotide polymorphism is associated with predisposition to tick-borne encephalitis virus-induced severe central nervous system disease. Ticks Tick Borne Dis. 2018;9(4):763–767. PubMed

Behl T., Kaur G., Sehgal A., Bhardwaj S., Singh S., Buhas C., Judea-Pusta C., Uivarosan D., Munteanu M.A., Bungau S. Multifaceted role of matrix metalloproteinases in neurodegenerative diseases: pathophysiological and therapeutic perspectives. Int. J. Mol. Sci. 2021;22(3) PubMed PMC

Bogdanavičienė K., Gudavičiūtė G., Šeškutė M. A retrospective analysis of tick-borne encephalitis in children treated in kaunas hospital during 2012 to 2019. Pediatr. Infect. Dis. J. 2022;41(9):702–705. PubMed

Bogovic P., Strle F. Tick-borne encephalitis: a review of epidemiology, clinical characteristics, and management. World J. Clin. Cases. 2015;3(5):430–441. PubMed PMC

Ergunay K., Tkachev S., Kozlova I., Růžek D. A review of methods for detecting tick-borne encephalitis virus infection in tick, animal, and human specimens. Vect. Borne Zoonot. Dis. 2016;16(1):4–12. PubMed

Fortova A., Hönig V., Palus M., Salat J., Pychova M., Krbkova L., Vyhlidalova T., Kriha M.F., Chrdle A., Ruzek D. Serum and cerebrospinal fluid phosphorylated neurofilament heavy subunit as a marker of neuroaxonal damage in tick-borne encephalitis. J. Gen. Virol. 2022;103(5):1–7. PubMed

Goetzl E.J., Banda M.J., Leppert D. Matrix metalloproteinases in immunity. J. Immunol. 1996;156(1):1–4. PubMed

Gudowska-Sawczuk M., Mroczko B. Selected biomarkers of tick-borne encephalitis: a review. Int. J. Mol. Sci. 2021;22(19):1–16. PubMed PMC

Kang X., Li Y., Wei J., Zhang Y., Bian C., Wang K., Wu X., Hu Y., Li J., Yang Y. Elevation of matrix metalloproteinase-9 level in cerebrospinal fluid of tick-borne encephalitis patients is associated with IgG extravassation and disease severity. PLoS ONE. 2013;8(11):e77427. PubMed PMC

Kohlmaier, B., Schweintzger, N.A., Sagmeister, M.G., Švendová, V., Kohlfürst, D.S., Sonnleitner, A., Leitner, M., Berghold, A., Schmiedberger, E., Fazekas, F., Pichler, A., Rejc-Marko, J., Růžek, D., Dufková, L., Čejková, D., Husa, P., Pýchová, M., Krbková, L., Chmelík, V., Štruncová, V., Zavadska, D., Karelis, G., Mickiene, A., Zajkowska, J., Bogovič, P., Strle, F., Zenz, W., n.d. The Eu-Tick-Bo Study, G., 2021. Clinical characteristics of patients with tick-borne encephalitis (TBE): a European multicentre study from 2010 to 2017. Microorganisms 9(7), 1–15. PubMed PMC

Korenberg E.I. Chapter 4. Recent epidemiology of tick-borne encephalitis an effect of climate change? Adv. Virus Res. 2009;74:123–144. PubMed

Krbková L., Čapovová I., Homola L., Lindušková J., Salát J., Růžek D. Tick-borne encephalitis in an 8.5-month-old boy suspected of febrile seizures. Microorganisms. 2021;9(7):1–4. PubMed PMC

Krbková L., Štroblová H., Bednářová J. Clinical course and sequelae for tick-borne encephalitis among children in South Moravia (Czech Republic) Eur. J. Pediatr. 2015;174(4):449–458. PubMed

Kríz B., Benes C., Daniel M. Alimentary transmission of tick-borne encephalitis in the Czech Republic (1997-2008) Epidemiol. Mikrobiol. Imunol. 2009;58(2):98–103. PubMed

Lakhan S.E., Avramut M. Matrix metalloproteinases in neuropathic pain and migraine: friends, enemies, and therapeutic targets. Pain Res. Treat. 2012;2012 PubMed PMC

Leppert D., Lindberg R.L., Kappos L., Leib S.L. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res. Brain Res. Rev. 2001;36(2–3):249–257. PubMed

Lesnicar G., Poljak M., Seme K., Lesnicar J. Pediatric tick-borne encephalitis in 371 cases from an endemic region in Slovenia, 1959 to 2000. Pediatr. Infect. Dis. J. 2003;22(7):612–617. PubMed

Malemud C.J. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front. Biosci. 2006;11:1696–1701. PubMed

Malyarchuk B.A., Grzybowski T., Derenko M.V., Czarny J., Woźniak M., Miścicka-Sliwka D. Mitochondrial DNA variability in Poles and Russians. Ann. Hum. Genet. 2002;66(Pt 4):261–283. PubMed

Mohammadhosayni M., Sadat Mohammadi F., Ezzatifar F., Mahdavi Gorabi A., Khosrojerdi A., Aslani S., Hemmatzadeh M., Yazdani S., Arabi M., Marofi F., Jadidi-Niaragh F., Shomali N., Mohammadi H. Matrix metalloproteinases are involved in the development of neurological complications in patients with Coronavirus disease 2019. Int. Immunopharmacol. 2021;100 PubMed PMC

Niranjan R., Kishor S., Kumar A. Matrix metalloproteinases in the pathogenesis of dengue viral disease: involvement of immune system and newer therapeutic strategies. J. Med. Virol. 2021;93(8):4629–4637. PubMed

Palus M., Bílý T., Elsterová J., Langhansová H., Salát J., Vancová M., Růžek D. Infection and injury of human astrocytes by tick-borne encephalitis virus. J. Gen. Virol. 2014;95(Pt 11):2411–2426. PubMed

Palus M., Vancova M., Sirmarova J., Elsterova J., Perner J., Ruzek D. Tick-borne encephalitis virus infects human brain microvascular endothelial cells without compromising blood-brain barrier integrity. Virology. 2017;507:110–122. PubMed

Palus M., Zampachová E., Elsterová J., Růžek D. Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in patients with tick-borne encephalitis. J. Infect. 2014;68(2):165–169. PubMed

Palyga-Bysiecka I., Kręcisz B., Szczepańska B. Clinical course and neurological sequels after tick-borne encephalitis in children - case report. Ann. Agric. Environ. Med. 2022;29(1):162–167. PubMed

Rostasy K. Tick-borne encephalitis in children. Wien. Med. Wochenschr. 2012;162(11–12):244–247. PubMed

Ruzek D., Avšič Županc T., Borde J., Chrdle A., Eyer L., Karganova G., Kholodilov I., Knap N., Kozlovskaya L., Matveev A., Miller A.D., Osolodkin D.I., Överby A.K., Tikunova N., Tkachev S., Zajkowska J. Tick-borne encephalitis in Europe and Russia: review of pathogenesis, clinical features, therapy, and vaccines. Antiviral Res. 2019;164:23–51. PubMed

Saksida A., Duh D., Lotric-Furlan S., Strle F., Petrovec M., Avsic-Zupanc T. The importance of tick-borne encephalitis virus RNA detection for early differential diagnosis of tick-borne encephalitis. J. Clin. Virol. 2005;33(4):331–335. PubMed

Salat J., Ruzek D. Tick-borne encephalitis in domestic animals. Acta Virol. 2020;64(2):226–232. PubMed

Shaw G. In: Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Kobeissy F.H., editor. CRC Press/Taylor & Francis; Boca Raton (FL): 2015. The use and potential of pNF-H as a general blood biomarker of axonal loss: an immediate application for CNS injury. Ed. PubMed

Shukla V., Shakya A.K., Dhole T.N., Misra U.K. Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of children with Japanese encephalitis virus infection. Arch. Virol. 2013;158(12):2561–2575. PubMed

Schmolck H., Maritz E., Kletzin I., Korinthenberg R. Neurologic, neuropsychologic, and electroencephalographic findings after European tick-borne encephalitis in children. J. Child Neurol. 2005;20(6):500–508. PubMed

Taba P., Schmutzhard E., Forsberg P., Lutsar I., Ljøstad U., Mygland Å., Levchenko I., Strle F., Steiner I. EAN consensus review on prevention, diagnosis and management of tick-borne encephalitis. Eur. J. Neurol. 2017;24(10):1214–e1261. PubMed

Vafadari B., Salamian A., Kaczmarek L. MMP-9 in translation: from molecule to brain physiology, pathology, and therapy. J. Neurochem. 2016;139(Suppl 2):91–114. PubMed

Yushchenko M., Weber F., Mäder M., Schöll U., Maliszewska M., Tumani H., Felgenhauer K., Beuche W. Matrix metalloproteinase-9 (MMP-9) in human cerebrospinal fluid (CSF): elevated levels are primarily related to CSF cell count. J. Neuroimmunol. 2000;110(1–2):244–251. PubMed

Zhou J., Marten N.W., Bergmann C.C., Macklin W.B., Hinton D.R., Stohlman S.A. Expression of matrix metalloproteinases and their tissue inhibitor during viral encephalitis. J. Virol. 2005;79(8):4764–4773. PubMed PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...